> ## Documentation Index
> Fetch the complete documentation index at: https://docs.hi-doctor.ai/llms.txt
> Use this file to discover all available pages before exploring further.

# Vardenafil (Levitra) — how it works and dosing

> Vardenafil for erectile dysfunction: how it works, EU authorisation history, trial results and reported side effects.

Vardenafil is a prescription tablet for erectile dysfunction, authorised
across the EU since 2003. It works the same way as sildenafil and tadalafil:
it keeps the blood vessels in the penis relaxed so blood can flow in during
sexual arousal. It must never be taken with nitrate heart medicines.

## What is vardenafil?

Vardenafil is a PDE5-inhibitor tablet, film-coated or melt-in-the-mouth, for
adult men with erectile dysfunction — the inability to achieve or maintain an
erection sufficient for satisfactory sexual performance. Sexual stimulation
is still required for it to work. It is normally taken 25 to 60 minutes
before sex, and it also comes as a tablet that dissolves on the tongue.

<Info>
  Active ingredient: vardenafil. Dosages: 5, 10 or 20 mg, taken on demand.
</Info>

## How it works

<CardGroup cols={3}>
  <Card title="Arousal releases nitric oxide" icon="bolt">
    Sexual stimulation makes nerves and blood vessel linings in the penis
    release nitric oxide, which switches on an enzyme called guanylate cyclase
    and builds up a messenger chemical called cyclic GMP in the erectile
    tissue.
  </Card>

  <Card title="Cyclic GMP opens the blood flow" icon="droplet">
    Cyclic GMP relaxes that smooth muscle, so arteries widen and blood flows
    into the corpus cavernosum. The body then steadily breaks the cyclic GMP
    down again.
  </Card>

  <Card title="Vardenafil blocks the clean-up enzyme" icon="lock">
    Vardenafil blocks the PDE5 enzyme that normally ends an erection, so the
    relaxation lasts and blood vessels stay filled during arousal.
  </Card>
</CardGroup>

## EU authorisation

Levitra is centrally authorised, so a single EU authorisation covers all 27
member states. It was granted on 6 March 2003 and is held by Bayer AG in
Germany. The 10 mg orodispersible tablet is taken without liquid and is a
different presentation from the 10 mg film-coated tablet, not an
interchangeable one.

## What the studies reported

<Note>
  Every NCT identifier links to its ClinicalTrials.gov record. A readout is not
  the same as peer-reviewed publication. Results below are grouped by source and
  evidence grade so journal data and manufacturer figures are not confused.
</Note>

The EMA product information reports fixed-dose success rates: SEP2 (ability to
penetrate) at 68% / 76% / 80% for 5 / 10 / 20 mg versus 49% on placebo, and
SEP3 (ability to maintain an erection) at 53% / 63% / 65% versus 29% on
placebo, measured over three months.

The pivotal at-home trial was a single 12-week manufacturer-sponsored study in
a mixed erectile-dysfunction population. The IIEF question-level changes are
small point movements on a 5-point scale, not percentages, which is worth
keeping in mind when comparing across different PDE5 inhibitor trials.

<AccordionGroup>
  <Accordion title="Sources">
    * EMA EPAR — Levitra (vardenafil), EMEA/H/C/000475, marketing authorisation issued 06/03/2003
    * EMA — Levitra EPAR product information (SmPC sections 4.2, 4.8, 5.1)
    * *Int J Impot Res* 2001 — first at-home clinical trial of vardenafil (PMID 11494074)
    * *J Androl* 2002 — vardenafil for treatment of men with erectile dysfunction: randomised, double-blind, placebo-controlled trial (PMID 12399521)
  </Accordion>
</AccordionGroup>

## What has been reported

| Effect                                                    | Frequency in EU product information | Reported in at-home pivotal trial |
| --------------------------------------------------------- | ----------------------------------- | --------------------------------- |
| Headache                                                  | Very common (>1 in 10)              | 7%–15%                            |
| Flushing                                                  | Common                              | 10%–11%                           |
| Dyspepsia or rhinitis                                     | Common                              | Up to 7%                          |
| Dizziness                                                 | Common (1 in 100 to 1 in 10)        | —                                 |
| Visual disturbance, ocular hyperaemia, colour distortion  | Uncommon (1 in 1,000 to 1 in 100)   | —                                 |
| Non-arteritic anterior ischaemic optic neuropathy (NAION) | Not known                           | —                                 |

Vardenafil is contraindicated in men who have already lost vision in one eye
from NAION.

## How to take it

Vardenafil is taken 25 to 60 minutes before sexual activity. Light meals are
fine, but very fatty meals delay onset. At most one dose is taken in 24 hours.
The orodispersible tablet is placed on the tongue and dissolves without liquid
— it is a different presentation from the film-coated tablet and is not
interchangeable.

## Common questions

<AccordionGroup>
  <Accordion title="How does vardenafil compare with sildenafil?">
    Both are PDE5 inhibitors that work the same way. Vardenafil has high
    selectivity for the PDE5 enzyme. Some people who had side effects with
    sildenafil tolerate vardenafil well — the reviewing doctor weighs which
    PDE5 inhibitor fits your case best.
  </Accordion>

  <Accordion title="Can I take vardenafil with food?">
    Light meals are fine, but very fatty meals delay the onset of effect.
    Vardenafil is normally taken 25 to 60 minutes before sex regardless of
    meals.
  </Accordion>

  <Accordion title="What happens if I take vardenafil and do not become aroused?">
    Vardenafil does not cause an erection on its own. Sexual stimulation is
    required for it to work, because the medicine only keeps the blood vessels
    relaxed once nitric oxide is released during arousal.
  </Accordion>

  <Accordion title="Can I take vardenafil if I have heart disease?">
    Vardenafil is contraindicated in men with severe cardiovascular disease
    and in anyone taking nitrate medicines or nitric-oxide donors (poppers),
    because blood pressure can fall dangerously. The reviewing doctor screens
    cardiovascular history before prescribing.
  </Accordion>

  <Accordion title="Is there a tablet that dissolves on the tongue?">
    Yes. The 10 mg orodispersible tablet dissolves on the tongue without
    liquid. It is a different presentation from the 10 mg film-coated tablet
    and not an interchangeable one.
  </Accordion>
</AccordionGroup>

## Who it is not suitable for

* Anyone taking nitrate medicines or nitric-oxide donors ("poppers") — blood pressure can fall dangerously
* Men with severe cardiovascular disease

<Warning>
  Nitrates and poppers are contraindicated with vardenafil: taken together, blood
  pressure can fall dangerously.
</Warning>

## How Hi-Doctor handles it

Some people who had side effects with sildenafil tolerate vardenafil well — the
doctor weighs which PDE5 inhibitor fits your case best, after screening your
cardiovascular history and current medicines. At most one dose is taken in 24
hours. See also [tadalafil](/library/medicines/tadalafil),
[sildenafil](/library/medicines/sildenafil), and
[avanafil (Spedra)](/library/medicines/spedra), another PDE5 inhibitor in the
same group with a faster onset. For the full eligibility checks, see
[safety](/essentials/safety) and [how a consultation
works](/essentials/how-it-works).

## Start a consultation

<Card title="Sexual health consultation" icon="stethoscope" href="https://hi-doctor.ai/consultation/sexual-health/1">
  Answer the sexual health questionnaire and a registered doctor reviews it.
  They decide whether treatment is appropriate, which one, and at what dose —
  and declining is a normal outcome. See [what it costs](/essentials/pricing)
  and [how the review works](/essentials/how-it-works).
</Card>

<Warning>
  This page is reference information, not medical advice and not a prescription.
  Whether a medicine is appropriate for you is decided by a registered doctor
  after reviewing your consultation.
</Warning>
